Bifendate | Interleukin Related interleukin-related.com

Product Name :
Bifendate

Search keywords :
Bifendate

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Apoptosis stimulants

First Approval Country :
Mainland China

First Approval Date Filter:
1984

Origin Company_Name :

Active Company_Name :
Harbin Guokang Pharmaceutical Co Ltd

Active Indication_Name:
Hepatitis, Chronic

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Hexokinase I (YP6080) Mouse mAb Technical Information
Bebtelovimab custom synthesis
Ku70 Antibody (YA319): Ku70 Antibody (YA319) is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Ku70. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts